The malaria-causing parasite, Plasmodium, contains a unique non-photosynthetic plastid known as the apicoplast. The apicoplast is an essential organelle bound by four membranes. Although membrane transporters are attractive drug targets, only two transporters have been characterised in the malaria parasite apicoplast membranes. We selected 27 candidate apicoplast membrane proteins, 20 of which are annotated as putative membrane transporters, and performed a genetic screen in Plasmodium berghei to determine blood stage essentiality and subcellular localisation.
encoding transport proteins (Martin et al., 2005) . This should therefore result in a low level of redundancy amongst Plasmodium transporters relative to the transportomes of other organisms (Martin et al., 2005) . Kenthirapalan, Waters, Matuschewski, and Kooij (2016) reported a genetic screen of 35 putative membrane transporters in Plasmodium berghei. During the disease causing blood stage of infection, 17.14% of these putative membrane transporters were found to have essential functions, 11.43% were required for normal growth, and 71.43% could be deleted with no growth defect or arrest across the life cycle . However, of the genes that could be deleted in the blood stage, 45% were found essential for completion of the life cycle, 31% were later required for normal growth, and only 24% were not needed for normal growth throughout the entire life cycle . More recently, Bushell et al. (2017) found that of the 79 transporters targeted for genetic deletion in blood stage P. berghei parasites, 33% were essential, 24% were necessary for normal growth, and 43% were dispensable. This may indicate that many membrane transporters have vital roles beyond the blood stage. Subcellular co-localisations were not provided in these studies, making it difficult to link any deletion effects with possible function within the cell.
A primary feature in eukaryotic cells is the compartmentalisation of function into various membrane bound organelles with different internal environments. Membrane transporters are essential for the function and maintenance of organelles as they regulate the movement of molecules across otherwise impermeable membranes. One of the most intriguing organelles in Plasmodium is the apicoplast (McFadden, Reith, Munholland, & Lang-Unnasch, 1996) . Derived from an algal chloroplast, the apicoplast contains many bacterial and plantlike pathways that are attractive drug targets because they differ markedly from pathways found in humans Ralph et al., 2004) . In the red blood cell stages, the only essential function of the apicoplast is the production of isopentenyl diphosphate (IPP; Yeh & DeRisi, 2011) . In in vitro culture, genes essential for apicoplast function, and even the entire apicoplast, can be deleted as long as the parasites are provided with a source of IPP (Gisselberg, Dellibovi-Ragheb, Matthews, Bosch, & Prigge, 2013; Yeh & DeRisi, 2011 ). This is not true for the mosquito and liver stages of the parasite life cycle, where other apicoplast metabolic pathways are essential (Ke et al., 2014; Nagaraj et al., 2013; Rathnapala, Goodman, & McFadden, 2017; van Schaijk et al., 2014; Yu et al., 2008) .
To maintain apicoplast metabolism, and thus ensure parasite survival, one or more of the apicoplast membranes must act as a selective molecular barrier. Canonical plant plastids (chloroplasts) have two membranes. The inner membrane contains a number of active transporters, and the outer membrane contains selective channels (Bölter & Soll, 2001; Fischer, 2011; Pick & Weber, 2014) . Four membranes surround the apicoplast as a result of its secondary endosymbiotic origins (Köhler et al., 1997; van Dooren & Striepen, 2013) . The outer apicoplast membrane is intermittently continuous with the parasite endomembrane system, and the second outermost "periplastid" membrane is derived from the red algal plasma membrane (van Dooren & Striepen, 2013) . The two innermost membranes of the apicoplast are homologous to the two membranes of the primary plastids of red algae and plants van Dooren & Striepen, 2013) . Little is known about the distribution of membrane transport processes across these four membranes and how apicoplast transporters interact to import molecules required to fuel apicoplast metabolism and export metabolites to the rest of the parasite. Mullin et al. (2006) characterised the first apicoplast membrane transporters, the inner and outer triose phosphate transporters, PfiTPT and PfoTPT, which are homologues of plant plastidic phosphate translocators (Weber & Linka, 2011) . A bipartite leader sequence targets PfiTPT to the innermost apicoplast membrane, whereas PfoTPT, which lacks a targeting leader, localises to the outermost apicoplast membrane (Mullin et al., 2006) . The plastidic phosphate translocators of Plasmodium were later found to fuel apicoplast metabolism by importing phosphoenolpyruvate, dihydroxyacetone, and 3-phosphoglycerate from parasite glycolysis in the cytosol (Brooks et al., 2010; Lim, Linka, Mullin, Weber, & McFadden, 2010) . Banerjee, Jaijyan, Surolia, Singh, and Surolia (2012) reported that during the blood stage of infection of the rodent malaria parasite, P. berghei, PboTPT was essential and PbiTPT was dispensable. However, PbiTPT KO parasites displayed growth defects in the mosquito and liver stages (Banerjee et al., 2012) . It was suggested that PboTPT can transport the PbiTPT substrate in blood stage parasites and that the two transporters might not work in tandem (Banerjee et al., 2012) . To date, the TPTs remain the only membrane transporters known to be localised to the apicoplast.
Here, we describe a medium throughput genetic screen for apicoplast membrane transporters in P. berghei. Candidate apicoplast membrane proteins, many of which are putative membrane transporters, were identified and then investigated using the PlasmoGEM vectors Pfander et al., 2011; Pfander, Anar, Brochet, Rayner, & Billker, 2012; Schwach et al., 2015) . In P. berghei, we localised these candidates by gene tagging and determined essentiality in the blood stage by gene knockout (KO) attempts. Gene knockdowns were performed for two apparently essential apicoplast putative membrane transporters in P. falciparum, and IPP supplementation was used to investigate the roles of one in apicoplast biogenesis.
| RESULTS

| Candidate apicoplast membrane transporters
We compiled a list of potential Plasmodium apicoplast membrane transporters (Table 1 ) from two sources: P. falciparum putative membrane transporters belonging to known transport families (Martin et al., 2005) and selected members of the predicted P. falciparum apicoplast proteome with multiple TMDs (Ralph et al., 2004) . Many P. falciparum membrane transporters have seven or more TMDs, whereas some have six or fewer (Martin et al., 2005) . Without biological data to confirm membrane transport activity, we selected candidate proteins predicted to have at least six TMDs (Table 1) . Although multiple TMDs is a minimum requirement of most membrane transporters, some of these proteins may be integral membrane proteins with other functions, in which case further investigation is required.
The first 10 candidates in Table 1 are predicted to be apicoplastlocalised; the remaining 17 apparently lack apicoplast targeting signals but were included in the hope of extending the list of non-canonically targeted apicoplast membrane transporters. All shortlisted candidates are predicted to contain at least six and up to 17 TMDs and have orthologues in both P. berghei and P. falciparum (Table 1) . Additionally, nine have Toxoplasma gondii orthologues, eight have orthologues in Theileria, six in Babesia, and 10 in Cryptosporidium (Table 1) . Those with orthologues in Cryptosporidium, a model apicomplexan species that lacks an apicoplast (Zhu, Marchewka, & Keithly, 2000) , were deprioritised. As a final criterion, we considered the level of blood stage expression of each candidate, namely, from very low to very high (Table 1) . Shortlisting led us to include 27 candidate proteins, 20 of which are putative membrane transporters and seven of which are putative integral membrane proteins, not currently annotated as transporters (Table 1) .
| Blood stage essentiality in rodent malaria
Initially, our genetic screen aimed to determine whether candidates were essential (parasites refractory to deletion) or non-essential (parasites survive deletion) during the blood stage of infection. This was achieved by attempting to delete candidate genes in P. berghei. Parasite lines were generated for 25 gene KO attempts, and PCR screening was performed to determine whether parasites lack the gene of interest or retain the wild-type (WT) locus (Figures 1a and S1 ). Nineteen candidates appeared to have successful integration of the KO vector, indicating that the genes of interest had been deleted (Figures 1a and S1 ). These 19 genes were considered to be non-essential for parasite survival at the blood stage. Six candidates were apparently essential for parasite survival at the blood stage as no PCR products detected integration of the KO construct ( Figure 1a) . Instead, PCR screening generally showed that these parasites retained only the WT locus, suggesting that random integration had occurred and that the gene could not be deleted in surviving parasites (Figures 1a and S1 ). Only deletion of PbANKA_0505500 yielded no parasites after three transfections with a KO construct. Therefore, PbANKA_0505500 was deemed probably essential at the blood stage but PCRs could not be included in Figure 1a (Table 1) .
We analysed a subset of the generated parasite lines, using Southern blotting to validate our genetic screen results. This confirmed our PCR results showing that PbANKA_0614600 and PbANKA_0942100 are probably essential ( Figures S2-S4) .
Additionally, the candidate apicoplast membrane transporter, PbANKA_0401200, was reported to be refractory to deletion by Rijpma et al. (2016) . We recovered parasites from only one of three transfections with the PbANKA_0401200 KO construct, and although our PCR results indicated that integration had occurred ( Figure S1 ), we set out to validate our positive result by Southern blot ( Figures S5-S6 ). The results of the Southern blot were unclear for integration of the KO construct ( Figure S6 ) so mRNA expression was examined by reverse transcriptase (RT)-PCR (Figure 1b,c) . Three primer pairs within the PbANKA_0401200 coding sequence amplified the expected WT product sizes from parasites carrying the PbANKA_0401200 KO construct (Figure 1b,c) . This suggested that an unusual integration occurred in PbANKA_0401200 KO parasites, where the gene locus was modified but the gene is still expressed.
We thus suggest that PbANKA_0401200 is essential at the blood stage.
PlasmoGEM transfection vectors are expected to have low rates of random integration and episomally maintained vectors (Pfander et al., Gene IDs are given for both P. berghei and P. falciparum orthologues and PlasmoDB annotations are shown, distinguishing between putative membrane transporters and putative integral membrane proteins. If a gene name has been assigned, it is given in brackets after the annotation. Presence of a gene orthologue in Toxoplasma gondii, Theileria, Babesia and Cryptosporidium is indicated by '+' and absence is shown by '-'. Transmembrane domains (TMD) were predicted in P. falciparum with TMHMM and TMpred. If there was a discrepancy, the TMHMM and strongest TMpred results are given (TMHMM/TMpred). Localisation was predicted with PlasmoAP and PATS in P. falciparum. P. berghei normalised expression for rings (R), trophozoites (T), schizonts (S) and gametocytes (G) (Otto et al., 2014) , was binned with thresholds on sample percentiles: 0-5% (Very low), 5-25% (Low), 25-75% (Moderate), 75-95% (High), 95-100% (Very high). For results: ND = no data, *localised in P. falciparum, Rijpma et al. (2016) , contradicted by Kenthirapalan et al. (2016) , confirmed by Rijpma et al. (2016) , Kenthirapalan et al. (2016) , confirmed by Kenthirapalan et al. (2016) , contradicted Rijpma et al. (2016) , confirmed by Bushell et al. (2017) , contradicted by Bushell et al. (2017) , mutant displays significantly slow growth (Bushell et al., 2017) . Each candidate was categorised by colour depending on blood stage essentiality and localisation results displayed in Figure 4 . by FIGURE 1 Candidate gene knockout PCR screen and reverse transcriptase-PCR in Plasmodium berghei. (a) PCR was performed on wild-type (WT) PbANKA and candidate gene knockout (KO) genomic DNA (gDNA) extracted from mixed population blood stage parasites. WT locus and integrant primers were used. PCR product bands were cropped from the correct well at the predicted product size of an ethidium bromide-stained agarose gel image. The PbANKA_1364800 KO integrant primers span the entire KO construct with less than a 650 BP size difference between the WT and KO predicted products, so both the WT and KO products are observed in the cropped region of the agarose gel indicating that both the WT locus and integrated KO vector are present in the parasite population. (b) Three primer pairs were designed within the PbANKA_0401200 coding sequence (CDS) to detect RNA expression, primers 1 (red), 2 (green), and 3 (blue). Primer positions and fragment sizes are shown on the gene schematic. RNA was extracted from clonal PbANKA_0401200 KO parasites and reverse-transcribed into cDNA. (c) Tubulin primers were included and each primer pair was used to amplify WT PbANKA gDNA (positive controls) and PbANKA_0401200 KO cDNA. No template control (NTC) and PCR reactions without reverse transcriptase (no RT) were used as negative controls. Reactions were electrophoresed, and PCR product bands were cropped from the correct well at the predicted product size of an ethidium bromide-stained agarose gel image. Primer type is given on left and sample type is given above 2011). However, in our experimental system, growth of parasites retaining the WT locus was common, indicating that many PlasmoGEM KO vectors can experience some random integration.
| Protein expression and apicoplast localisation
Sixteen candidate genes were HA-tagged for localisation experiments in P. berghei. PCR screening confirmed that all parasite lines contain the HA-tag (TAG) vector ( Figure S7 ) and expression of the tagged protein was confirmed by Western blot (Figure 2a ). Thirteen candidates had bands of the appropriate mass congruent with gene models (Figure 2a ), and three (PbANKA_0942100, PbANKA_0410500, and PbANKA_0916000) likely suffer from electrophoresis anomalies common to membrane proteins (Kaur & Bachhawat, 2009 ).
PbANKA_0809500 TAG protein could not be detected in blood stage parasites (data not shown), which have low expression of the gene (Table 1) , so protein was extracted from sporozoite parasites where expression was higher. Particularly faint signal was observed for PbANKA_0417100 ( Figure 2a ), which is lowly expressed during the blood stages (Table 1) . Tagged parasite lines were also generated in P. falciparum. Pf3D7_1145500-GFP (PbANKA_0903500 orthologue) had two GFP bands that were smaller than the predicted mass; the smallest may be dissociated GFP (Figure 2b ). Finally,
Pf3D7_0716900-glmS
(PfDMT2-glmS), Pf3D7_0302600-glmS (PfABCB4-glmS), and Pf3D7_0302600-HA (PfABCB4-HA) had HA bands at the predicted masses (Figures 2c and S8 ).
Immunofluorescence assays (IFAs) were performed for all tagged candidate genes. Seven candidates co-localised with the apicoplast marker, ACP (Figure 3a ,b). PbANKA_0809500, PbANKA_0401200, PbANKA_0505500, and Pf3D7_1145500 were all predicted to have apicoplast targeting leader sequences whereas PbANKA_1103600, PbANKA_1304700, and PfDMT2 were not predicted to contain leader sequences ( Figure 3a ,b and Table 1 ). Another seven candidates localised to non-apicoplast structures within the parasite (Figure 3d ). Four candidates had no observable immunofluorescence signal at the blood stage so could not be localised in this life cycle stage:
PbANKA_0942100, PbANKA_0417100, PbANKA_1446100, and PbANKA_0602400 (data not shown). Life cycle analysis of two candidates (PbANKA_1103600 and PbANKA_0942100) revealed that PbANKA_1103600 TAG was expressed and localised to the apicoplast in midgut oocysts, salivary gland sporozoites, and in vitro liver cell stage parasites ( Figure 3c ). No signal was observed for PbANKA_0942100
FIGURE 2 Tagged candidate protein expression and Pf3D7_0716900-glmS knockdown. (a) Western blot analysis was performed on each HAtagged (TAG) candidate in Plasmodium berghei. Parasite protein was extracted and separated by SDS-PAGE, transferred to a membrane, and visualised by probing with rat anti-HA primary and anti-rat HRP secondary antibodies. Protein band masses are shown by a standard marker (left). Parasite protein was extracted during the blood stage, except for PbANKA_0809500 TAG, which was taken from sporozoites. (b) Pf3D7_1145500-GFP (ABCB3) blood stage expression. Protein was probed with mouse anti-GFP primary and anti-mouse HRP secondary antibodies. Western blots were also performed once on protein extracted from the following sorbitol-synchronised parasites over 120 hr: (c) Pf3D7_0716900-glmS (DMT2-glmS clone B11) without glucosamine (GlcN) and (d) DMT2-glmS clone B11 with GlcN. Molecular mass markers are shown on left and antibodies are given on right. Anti-HA was used to monitor DMT2-glmS expression and anti-BiP as a protein loading control. Wild-type (WT) 3D7 protein was included as a negative control for non-specific antibody binding. To quantify protein expression, the data were normalised to BiP by calculating the ratio of HA to BiP signal (e) to compare DMT2-glmS expression with and without GlcN FIGURE 3 Immunolocalisation of putative membrane proteins in Plasmodium. (a) Plasmodium berghei and Plasmodium falciparum (PfDMT2-glmS clone D6, PfABCB4-HA clone G3, and PfABCB4-glmS clone F11) candidate proteins were HA-tagged and probed with rat anti-HA primary and anti-rat 488 secondary antibodies (green). The apicoplast was probed with rabbit anti-ACP primary and anti-rabbit 546 secondary antibodies (red) and nuclei were stained with Hoechst (blue). Channels were merged with a transmission image (right) showing the location within the parasite. All candidates were localised within red blood cell stage parasites except PbANKA_0809500, which was localised in a sporozoite. Scale bars are 2 μm.
(b) Pf3D7_1145500-GFP was localised in an intraerythrocytic parasite probed with mouse anti-GFP primary and anti-mouse 488 secondary antibodies (green; scale bar is 2 μm). (c) PbANKA_1103600 TAG parasites were localised in oocyst, sporozoite, and in vitro liver cell stage parasites. Scale bars are 5 μm. (d) Seven candidates were also localised to non-apicoplast structures within intraerythrocytic parasites (scale bars are 2 μm) TAG parasites at any life cycle stage so its localisation remains unknown (data not shown).
The results of the screen are summarised in Figure 4 , highlighting the essentiality of the candidates and whether they are localised to the apicoplast. The characteristics of each candidate gene are represented in Table 1 by colour-coded categories based on their location in the Venn diagram (Figure 4 ).
| Knockdown of essential apicoplast putative membrane transporters in human malaria
Two candidates, identified as blood stage essential in the P. berghei genetic screen (PbANKA_0401200 and PbANKA_0614600: PbABCB4
and PbDMT2, respectively), were followed up with conditional knockdowns of orthologues in the human malaria parasite, P. falciparum (Pf3D7_0302600 and Pf3D7_0716900: PfABCB4 and PfDMT2, respectively). Glucosamine (GlcN)-induced glmS ribozyme knockdowns (Prommana et al., 2013) were generated and clonal integrant, 2.5 | PfDMT2 knockdown is lethal but can be rescued with IPP supplementation PfDMT2-glmS parasites were grown with different combinations of 2.5 mM GlcN and/or 200 μM IPP to determine whether PfDMT2 knockdown abrogates growth and whether a growth phenotype can be rescued by supplying exogenous IPP ( Figure 6 ). As expected, IPP alone had no effect on the growth or morphology of PfDMT2-glmS parasites in a 6-day growth trial (Figure 6 ). Addition of GlcN to control parasites with IPP supplementation also had no effect on growth The effects of GlcN treatment are reversible as long as parasites remain viable (Prommana et al., 2013) . PfDMT2 knockdown parasites could recover when GlcN was removed after 12 days of treatment ( Figure S13 Candidate gene PCR screen in Plasmodium falciparum. PCR was performed on wild-type (WT) 3D7, Pf3D7_0302600-HA (clone G3), and Pf3D7_0716900-glmS (clone B11) genomic DNA (gDNA) extracted from blood stage parasites. WT locus and integrant primers were used. PCR product bands were cropped from the correct well at the predicted product size of an ethidium bromide-stained agarose gel image could be recovered after 14 days in culture with GlcN, after which PfDMT2 expression was detected ( Figure S13 ).
| Rescued PfDMT2 knockdown parasites are apicoplast-minus
To test whether knocking down PfDMT2 resulted in loss of the apicoplast, we used real-time quantitative PCR to assess the impact of the PfDMT2 knockdown on the apicoplast genome ( Figure 7) . By assessing the ratio of a single copy apicoplast gene to a single copy nuclear gene, and including a mitochondrial gene as a control, we measured the impact of GlcN and IPP on the apicoplast of PfDMT2-glmS parasites across three 48-hr red blood cell life cycles (Figure 7 ). In the absence of IPP and GlcN, both PfDMT2-glmS and control parasites retain the apicoplast genome (Figure 7 ). In contrast, in PfDMT2-glmS parasites exposed to GlcN but rescued with IPP, there was no evidence of the apicoplast genome after three or six 48-hr life cycles (Figures 7 and S14 ). Apicoplast loss in these parasites was confirmed by IFA with no defined apicoplast structure visible in PfDMT2-glmS parasites treated with IPP and GlcN ( Figure S15 ). ). However, there is a lack of biological data FIGURE 6 Pf3D7_0716900 knockdown IPP supplementation growth assay and parasite morphology. In one replicate, sorbitol-synchronised Pf3D7_0716900-glmS (DMT2-glmS clone B11) and Pf3D7_0302600-HA (ABCB4-HA clone G3) control parasites were grown for up to 12 days with or without IPP and glucosamine (GlcN). (a) Treatment timelines for each culture are shown in the colour-coded table. As controls, HA parasites were grown with IPP and GlcN (+IPP+GlcN), and glmS parasites were grown without IPP and GlcN (−IPP−GlcN) for 6 days. On Day 6, cultures were discontinued, continued with the same treatment, or continued with a different treatment. Colour links a continued culture with the original culture (cultures coloured light blue, purple, and green, all originate from the same +IPP+GlcN culture coloured dark blue). Growth was monitored by daily blood smears, and parasitaemia was determined by calculating the percentage of infected red blood cells. Parasite growth is shown in Figure 6b . Dotted vertical lines on the graph every 2 days indicate when the cultures were subbed. "x" indicates when a culture was discontinued. (c) Parasite morphology was monitored by daily blood smears for membrane transporters in Plasmodium, particularly for those on intracellular membranes (Kirk, 2004; Krishna et al., 2001 ). Only two apicoplast membrane transporters have been characterised to date (Mullin et al., 2006) . It continues to be crucial to understand how molecules pass across the apicoplast membranes to fully understand Plasmodium biology and potentially offer novel drug targets. We set out to expand our understanding of apicoplast membrane transporters and their potential as drug targets by undertaking a medium throughput genetic screen addressing two central questions: Which proteins are essential for parasite survival at the blood stage, and which are localised to the apicoplast?
Five putative membrane transporters and three putative integral membrane proteins were identified as apparently essential at the P. berghei blood stage, flagging them as potentially good drug targets worthy of further characterisation. Two of these putative membrane transporters, PbANKA_0614600 (DMT2) and PbANKA_0401200 (ABCB4), and one of the putative integral membrane proteins, PbANKA_0505500, were apicoplast-localised. PfDMT2 is a putative drug/metabolite transporter. Knockdown of PfDMT2 prevents parasites from replicating in the second cycle; a phenotype reminiscent of the "delayed death" response to apicoplast-targeting drugs described in Plasmodium and other apicomplexan parasites (Fichera, Bhopale, & Roos, 1995; Goodman, Su, & McFadden, 2007) . Parasites treated with delayed death drugs can be rescued in culture by the addition of IPP, the only essential metabolic product of the apicoplast during the red blood cell stage (Yeh & DeRisi, 2011 One important consideration when screening for Plasmodium apicoplast membrane transporters is the potential exclusion of candidates based on the absence of predicted targeting motifs. Current prediction tools (Foth et al., 2003; Zuegge, Ralph, Schmuker, McFadden, & Schneider, 2001 ) are designed to predict the probability of a P. falciparum protein containing a canonical bipartite leader sequence.
PfoTPT, one of the first apicoplast membrane transporters characterised and localised to the outer membrane, does not contain a leader (Mullin et al., 2006) and was not predicted to be apicoplast- A number of leaderless candidate membrane proteins were included in our genetic screen with the hope of identifying further leaderless apicoplast membrane transporters. This proved successful with the identification of three novel leaderless apicoplast putative membrane transporters: DMT2, PbANKA_1103600 (ATP3), and PbANKA_1304700 (MFS6). Intriguingly, protein alignments revealed that these novel leaderless apicoplast proteins contain conserved N-terminal tyrosines just upstream of, or within, the first TMD ( Figure S16 ). These proteins provide a starting point for dissecting FIGURE 7 Organellar DNA in Pf3D7_0716900 knockdown IPP rescued parasites. The ratio of mitochondrion and apicoplast DNA to nuclear DNA in IPP rescued parasites relative to wild-type (WT) parasites was measured by real-time PCR. Genomic DNA was extracted from WT 3D7 parasites, Pf3D7_0716900-glmS (DMT2-glmS clone B11) parasites growing without treatment (−IPP−GlcN), and with IPP and glucosamine (GlcN) for 12 days (+IPP+GlcN). Pf3D7_0302600-HA (ABCB4-HA clone G3) parasites growing without treatment (−IPP−GlcN) were included as a positive control. Reactions were performed in triplicate and the organellar to nuclear DNA (1.0) ratio was normalised relative to WT levels the process of leaderless apicoplast targeting by determining the universality of the N-terminal tyrosine in apicoplast targeting and whether it is outer membrane specific.
In addition to the blood stage essential candidates identified here, we found 18 candidates to be non-essential for blood stage growth. Furthermore, Rijpma et al. (2016) determined that our candidate PbANKA_0903500 (ABCB3) is not essential at the blood stage.
Together, 70% of our candidate proteins could be deleted in blood stage P. berghei parasites. Although termed non-essential in this study, it is important to consider that parasite fitness was not measured so a number of these candidates may be required for normal growth and become essential when in competition with other parasites in the field. Four of these 19 non-essential candidates were apicoplast-localised in this study: three putative membrane transporters (ABCB3, ATP3, and MFS6) and one putative integral membrane protein (PbANKA_0809500). Our blood stage essentiality results are largely consistent with recent findings (Bushell et al., 2017; Kenthirapalan et al., 2016; Rijpma et al., 2016) and combining these gives a broader understanding of the make-up of the putative parasite and apicoplast transportomes. It is becoming apparent that a number of Plasmodium putative membrane transporters can be deleted in blood stage parasites, shifting focus to the essential roles of membrane transporters during the mosquito and liver stages.
Interestingly, there are some differences in our combined Plasmodium transportome essentiality data. PbANKA_1364800 (ABCB6) was found to be essential at the blood stage when Rijpma et al. (2016) could not generate ABCB6 KO parasites in P. berghei or P. falciparum, and Bushell et al. (2017) deemed PbABCB6 probably essential for blood stage growth. This is contrary to our results, where we deleted
PbABCB6 in blood stage parasites. Further, we were unable to detect integrated PbANKA_0107700 (ZIP1) KO blood stage parasites and deemed it probably essential. In contrast, Kenthirapalan et al. (2016) generated ZIP1 KO blood stage parasites that had a growth defect and could not infect mosquitoes. Later experiments also generated PbZIP1 KO parasites that grew significantly slower during the blood stage (Bushell et al., 2017) . Bushell et al. (2017) reported several other contrasting results that PbANKA_1429300 and PbABCB4 are dispensable, and PbATP3 and PbANKA_1446100 are essential for blood stage growth.
It is noteworthy that the recovery of KO parasites may depend on the mutagenesis system used and that growth defects can have different impacts depending on the assays used. Rijpma et al. (2016) also reported that PbABCB3 KO parasites had a severe blood stage growth defect although PfABCB3 KO parasites had no growth defect in asexual blood stage or mosquito stage parasites. The conflicting reports between P. berghei and P. falciparum ABCB3 orthologues are a reminder that although these species are often considered somewhat equivalent, they are different and require independent validation to determine whether a gene has the same role in both organisms.
It is important to consider blood stage redundancy before embarking on any targeted drug development strategy. The parasite undergoes remarkable morphological changes during its life cycle (Hall et al., 2005 ) so it should not be surprising that transportome proteins are switched on and off as the parasite changes between diverse host environments. It is vital to distinguish between membrane transporters that are essential for parasite growth at some stage (growth arrest phenotype) and membrane transporters that are likely redundant and completely dispensable (no growth phenotype at any stage). Life cycle studies will hopefully address the question of whether blood stage dispensable genes are essential FIGURE 8 Novel apicoplast putative membrane proteins in Plasmodium. The two previously characterised apicoplast membrane transporters, iTPT and oTPT, are shown on the inner and outer membranes. Dependent on whether they have an apicoplast leader, the predicted positions of five novel apicoplast putative membrane transporters (orange), and two novel apicoplast putative integral membrane proteins (blue), are shown. Membrane proteins with a leader are predicted to localise to the inner apicoplast membrane, as iTPT does. Candidates without a leader are predicted to localise to the outer apicoplast membrane, as oTPT does elsewhere. Genes essential in pre-erythrocytic or transmission stages are ideal candidates for transmission or prophylactic drugs, which are essential in world malaria control efforts to prevent disease spread and ultimately support eradication.
In summary, we have generated biological data for a number of Plasmodium putative membrane transporters and integral membrane proteins, including five apicoplast putative membrane transporters and two apicoplast putative integral membrane proteins. This study has vastly expanded our knowledge of what proteins reside in the apicoplast membranes and boosted the running total to nine membrane proteins (Figure 8 ). The identification of three novel leaderless apicoplast putative membrane transporters confirms the existence of a cohort of non-canonically targeted apicoplast membrane transporters and should prove useful in the search for novel apicoplast targeting mechanisms and reveal a great deal about apicoplast biology.
Heterologous expression and transport assays will be vital in confirming any transporter roles and determining any substrate specificities of the three new apparently blood stage essential apicoplast potential membrane transporters identified here, one of which is not currently predicted to be a transporter. Defining the function of PfDMT2 in the apicoplast will be a major new insight. The Plasmodium apicoplast continues to be an attractive drug target that is unique from its mammalian host. Although there is still a lot to learn about the Plasmodium transportome, this work provides a platform for future studies to achieve a better understanding of apicoplast biology and identify novel molecular targets to treat or prevent malaria.
| EXPERIMENTAL PROCEDURES
| Candidate gene selection
Potential Plasmodium apicoplast membrane transporters were shortlisted from two lists: 80 P. falciparum putative transport proteins (Martin et al., 2005) and 392 predicted P. falciparum apicoplast proteins that contain multipleTMDs (Ralph et al., 2004) . The lists were screened using the Plasmodium genome database (PlasmoDB) version 30 (Aurrecoechea et al., 2009) , and protein localisation predictions were performed with PlasmoAP (Foth et al., 2003) and PATS (Zuegge et al., 2001 ). Gene orthologues were obtained for each candidate from OrthoMCL (Li, Stoeckert, & Roos, 2003) , and TMD predictions were generated by TMHMM version 2.0 (http://www.cbs.dtu.dk/services/ TMHMM/) and TMpred (http://www.ch.embnet.org/software/ TMPRED_form.html). Candidates with at least one prediction of six TMDs were selected. Although some candidate proteins with multiple TMDs may not be membrane transporters, they were included due to the difficulty in definitively predicting membrane protein structure from protein sequence. Finally, P. berghei blood stage expression data were obtained for all candidates (Otto et al., 2014) and binned with thresholds on sample percentiles. and D10 strain parasites were maintained as previously described (Trager & Jensen, 1976) in 2% haematocrit in RPMI-Hepes (WEHI)
supplemented with Albumax II (Gibco) and sodium bicarbonate.
| Transfection vectors
Twenty-three KO and 16 HA-tag (TAG) transfection vectors were sourced from PlasmoGEM (plasmogem.sanger.ac.uk; Table S1 ). Three candidate genes were predicted to be apicoplast-localised and did not have PlasmoGEM KO transfection vectors available at the time.
Double crossover homologous recombination KO constructs were therefore made for PbANKA_0942100, PbANKA_0401200, and PbANKA_0505500 ( Figure S17a ). Typical KO and tagging strategies for all candidates are outlined in Figure S17 . Primers were used to generate homologous 5′ and 3′ gene specific flanks (Table S2) Table S3 . BglII and PstI were used to ligate each flank into glmS and HA transfection vectors (Elsworth et al., 2014) .
Final plasmid DNA was sequenced by the Australian Genome Research Facility with SP6, 5′-agctgccatatccctcgac, 5′-tgcacacaacatacacatttttac, 5′-tgtaaaacgacggccagt (M13-forward), and 5′-tccaatgtgcatgataaaagaaa primers.
| Parasite transfection
Approximately 10 μg of P. berghei DNA was linearised by NotI (PlasmoGEM vectors) and EcoRI/HindIII (pLDC vectors), and electroporated into WT PbANKA schizonts with an Amaxa
Nucleofector Device (Lonza), as previously described (Janse, Ramesar, & Waters, 2006) . After 24 hr, pyrimethamine (TCI) was added to the mouse drinking water to a final concentration of 70 μg/ml. Mice were typically monitored for pyrimethamine-resistant parasites until Day 14 post infection. Candidate genes were considered to be probably essential at the blood stage if mice remained uninfected after 14 days. At least three biological replicates were performed in this case to confirm the negative result. Using the standard transfection protocol (Crabb & Cowman, 1996; Wu, Sifri, Lei, Su, & Wellems, 1995) , approximately 100 μg of Pf3D7_1145500-GFP plasmid DNA (gift from Liting Lim)
was electroporated into ring stage WT P. falciparum D10 strain parasites and Pf3D7_0302600-glmS, Pf3D7_0302600-HA, and Pf3D7_0716900-glmS plasmid DNA into ring stage WT P. falciparum 3D7 strain parasites. On Day 2, 1 pM/ml WR (Sigma-Aldrich) was added. WR-resistant parasites were recovered after 15 to 30 days.
To encourage the plasmid DNA to integrate into the parasite genome, parasites were cycled off WR twice, for 3 weeks at a time.
| Parasite genotyping
In general, clonal parasites were not required in the P. berghei screen and mixed parasite populations were analysed. However, a clonal population of PbANKA_0401200 KO parasites was required for Southern blot and RT-PCR analyses. A clonal line was recovered after diluted parasites were inoculated into 10 naïve mice. Clonal populations of all P. falciparum parasite lines were recovered after diluting in 96-well plates. Pyrimethamine-resistant parasite populations were screened with PCR primers detecting the WT locus, successful integration, and presence of the transfection vector ( Figure S17 and; Tables 4-5).
PCR primers also detected the WT locus and successful integration of WR-resistant parasites ( Figure S18 and Table S6 ). A Southern blot was performed on PbANKA_0401200 KO clonal parasite and PbANKA_0942100 KO and PbANKA_0614600 KO parasite gDNA using the gene-specific 5′ flank and DHFR sequences as probes. To generate digoxigenin-labelled (Roche) probes, PbANKA_0942100 and PbANKA_0401200 utilised the 5′ flank cloning primers (Table S2) and PbANKA_0614600 used 5′ flank primers (5′-gcaatgcgttttgtgcttag and 5′-gcttccaccgcaaatttattc). A standard DHFR probe was also used ( Figure S19 ). Additionally, RNA was extracted from PbANKA_0401200 KO clonal parasites for cDNA synthesis with SuperScript III Reverse Transcriptase (Invitrogen). To determine whether PbANKA_0401200 was expressed in KO parasites, primers were designed within the coding sequence for RT-PCR (Table S7 ).
| Generating pre-erythrocytic stage parasites
PbANKA_1103600, PbANKA_0942100, and PbANKA_0809500 TAG parasite lines were used to infect approximately 100 naïve female
Anopheles stephensi strain MR4 mosquitoes. Mosquito midgut oocysts were typically harvested from Day 9 post infection and salivary gland sporozoites from Day 20 post infection. Furthermore, human hepatoma HepG2 cells (ATCC) were grown (Hollingdale, Leland, & Schwartz, 1983) and infected with PbANKA_1103600 and PbANKA_0942100 TAG sporozoites.
| Western blot analysis
Saponin-isolated intraerythrocytic parasites were resuspended in reducing buffer and heated to 70°C before analysis. For sporozoite protein, approximately 100,000 sporozoites were released from mosquito salivary glands to which reducing buffer was added before freezing. Protein samples were electrophoresed using the NuPAGE system (1:100; Roche), rat anti-BiP antibody (1:500; ATCC) or apicoplast marker acyl carrier protein (ACP) anti-serum, rabbit anti-ACP (1:250). (Schindelin et al., 2012) .
| Immunofluorescence assays
Infected blood, diluted to 1% in RPMI-Hepes with sodium bicarbonate, was adhered to 0.5 mg/ml concanavalin A (conA, Type V; SigmaAldrich)-coated 1.5 coverslips (Leica) as described (McMillan et al., 2013) . Cells were fixed with 4% paraformaldehyde, 0.005% to Hoechst 33342 (1:10,000; Thermo Fisher Scientific) was included in the first few washes. Cells were mounted with 0.01% DABCO (Sigma-Aldrich) in 50% glycerol and 1X DPBS. The same antibodies were used in the following pre-erythrocytic parasite IFAs.
Infected midguts were fixed in 4% paraformaldehyde in 1X DPBS for 1 hr. Blocking and permeabilisation were performed at 4°C overnight in 0.25% Triton X-100 in 5% BSA. Midguts were incubated with primary antibodies for at least 4 hr with shaking before washing three times with 1X DPBS. Samples were then incubated in secondary antibodies for 2 hr on an orbital shaker and then left at 4°C overnight.
Midguts were washed three times with the second wash containing
Hoechst. Finally, midguts were mounted with DAKO (Agilent). Sporozoites were added to 3% BSA-coated coverslips and incubated at DPBS was added for 20 min for permeabilisation. After washing, 3%
BSA in 1X DPBS was added for 30 min before the liver cell-coated coverslips were placed on the primary antibodies for 1 hr. Coverslips were washed three times before being placed on secondary antibodies containing Hoechst for 1 hr. The coverslips were washed then mounted with DAKO. IFAs were imaged on an inverted Leica SP2 or Nikon A1R confocal microscope with a 63X oil immersion objective. Image brightness, contrast, and noise were adjusted in Fiji (Schindelin et al., 2012) when appropriate, and images were merged.
| Protein alignments
Gene orthologues and protein sequences were obtained from PlasmoDB and OrthoMCL (Aurrecoechea et al., 2009; Li et al., 2003) and predicted TMD locations were generated by HMMTOP (Tusnády & Simon, 1998 ). Clustal Omega (1.2.2) Multiple Sequence Alignment (Sievers et al., 2011) was used to align gene orthologue protein sequences.
| P. falciparum growth assays
The fluorescence-based technique for drug trials in P. falciparum was used to determine the effect of GlcN (Sigma-Aldrich) on WT 3D7, ABCB4-HA, and ABCB4-glmS parasite growth (Smilkstein, Sriwilaijaroen, Kelly, Wilairat, & Riscoe, 2004) . Data were normalised to no drug and no parasite controls before a logarithmic drug curve was plotted with GraphPad Prism version 7.0b. For IPP supplementation, PfDMT2-glmS and control parasites were grown in 5 ml cultures for up to 18 days with different treatments of 2.5 mM GlcN and 200 μM IPP (Yeh & DeRisi, 2011) . Cultures were smeared every 24 hr, which were imaged with a Leica DM2500 microscope using a 40X objective and a Leica DC300F camera. A Giemsa-Counter plugin in Fiji (Schindelin et al., 2012) 
| Real-time PCR
Primers were designed to target genes in the mitochondrial, apicoplast, and nuclear genomes (Table S8) , which were used to amplify DNA extracted from IPP supplemented and control parasites. A 2X KAPA SYBR FAST qPCR Master Mix (Universal; Kapa Biosystems) was used for real-time PCR reactions with the following conditions: 95°C (3 min, 1 cycle), 95°C (10 s), 60.2°C
(30 s, 40 cycles), and 60 to 95°C (5 s, increasing 0.5°C per hold).
Every reaction was performed in triplicate and the quantification cycle (Cq) values were obtained for each. The relative quantification of gene expression, or the ratio of organellar to nuclear DNA relative to WT, was then calculated as previously described (Schmittgen & Livak, 2008) .
